| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 292.863 | 135.415 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 293.571 | 135.750 | 47 | 39 | 21 | 11 | - | - | - | - |
| Total Expenses - EUR | 170.986 | 110.595 | 1.096 | 316 | 1.108 | 117 | - | - | - | - |
| Gross Profit/Loss - EUR | 122.585 | 25.155 | -1.049 | -278 | -1.088 | -106 | - | - | - | - |
| Net Profit/Loss - EUR | 122.585 | 25.155 | -1.049 | -278 | -1.088 | -106 | - | - | - | - |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Medipharm Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.410 | 5.193 | 5.105 | 5.011 | 4.914 | 4.821 | - | - | - | - |
| Current Assets | 1.037.115 | 969.575 | 953.074 | 935.583 | 967.212 | 951.359 | - | - | - | - |
| Inventories | 28.128 | 72.151 | 70.930 | 69.628 | 68.280 | 66.986 | - | - | - | - |
| Receivables | 954.817 | 841.059 | 826.826 | 811.653 | 845.682 | 832.133 | - | - | - | - |
| Cash | 54.170 | 56.366 | 55.317 | 54.302 | 53.250 | 52.241 | - | - | - | - |
| Shareholders Funds | -188.803 | -161.723 | -160.035 | -157.376 | -155.416 | -152.575 | - | - | - | - |
| Social Capital | 97.504 | 96.510 | 94.876 | 93.135 | 91.332 | 89.600 | - | - | - | - |
| Debts | 1.267.474 | 1.177.624 | 1.158.651 | 1.137.665 | 1.166.469 | 1.146.944 | - | - | - | - |
| Income in Advance | 5.411 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medipharm Medical Srl